The Innovative Heart of Nordic Life Science
Evolving technology and the global demand for innovative health care solutions make Greater Copenhagen the perfect location for two converging industries: life science and tech. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news
Greater Copenhagen-The Innovative Heart of Nordic Life Science
Evolving technology and the global demand for innovative health care solutions make Greater Copenhagen the perfect location for two converging industries: life science and tech. This is your chance to get a free business brief about our HealthTech in … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news
Greater Copenhagen-Company white papers
Evolving technology and the global demand for innovative health care solutions make Greater Copenhagen the perfect location for two converging industries: life science and tech. This is your chance to get a free business brief about our HealthTech in … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news
Zenith Achieved ISO9001:2015 Certification
The ISO9001 accreditation demonstrates that organisations have proven their quality management systems (QMS) are as effective as possible through continual improvement and regular assessments. This is especially important for Zenith as a qualified su … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news
Custom Purification of Injectable Polymers via Carbon Dioxide Dissolution
Pierre Fabre M é dicament's Supercritical division has devised a smart, GMP-compliant and industrialised process to extract monomers from injectable polymer substances. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news
Gates Foundation supports development of Immunocore ’s therapeutics for infectious diseases
Immunocore has secured up to $40m in investment from Bill& Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases, in particular tuberculosis (TB) and human immunodeficiency … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
Mining fungi: a fountain of new medicines?
While fungi are a rich source of natural molecules, it has historically been hard to identify and capture these in a systematic way. Now a new technology platform, developed by researchers at Northwestern University and their partners, promises to sp … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
Teva to sell assets in global women ’s health business for $1.38bn
Teva Pharmaceutical Industries has entered two agreements to divest the remaining stake in its specialist global women ’s health business for $1.38bn. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells
A new study conducted by researchers from the National University of Singapore (NUS) has revealed that the co-treatment using artemisinin and aminolaevulinic acid (ALA) can potentially kill cancer cells and suppress tumour growth with fewer side effe … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
An Active Refrigeration Model for Sea Transport and Local Storage Solutions
Klinge Corporation has long been known for its proven solutions in the Dangerous Goods market, where specialised dual-redundant shipping containers keep products at the right temperature, avoiding potentially catastrophic failures, which could result … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
Streamlined and Cost-Effective Wet Formulation Development
MVIC's FD concept offers a streamlined, cost-effective, and high-quality performed inhalation formulation development package for customers that either lack resources to perform a development programme or require cutting-edge input for problem solvin … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
Register for Medicon Valley Inhalation Symposium (MVIS)
MVIC has announced that professionals wishing to visit the Medicon Valley Inhalation Symposium (MVIS) conference can now register. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 18, 2017 Category: Pharmaceuticals Source Type: news
Amgen and Allergan ’s anti-cancer biosimilar Mvasi receives FDA approval
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) for the treatment of five types of cancer. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 17, 2017 Category: Pharmaceuticals Source Type: news
Italvacuum to Attend POWTECH
Italvacuum has announced it is going to participate at POWTECH, a leading trade fair for processing, analysis, and handling of powder and bulk solids. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 17, 2017 Category: Pharmaceuticals Source Type: news
Novo Nordisk Pharmatech Showcases Recombinant Insulin at BioProcess International Conference and Exhibition
Novo Nordisk has announced it will be attending the BioProcess International conference and exhibition. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 17, 2017 Category: Pharmaceuticals Source Type: news
